TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding TFF Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 41 | 36 | −5 |
| Shares | 7.23M | 7.00M | −226.6K (−3.1%) |
| Value | $7.52M | $4.80M | −$2.73M (−36.3%) |
New holders (3)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Meridian Wealth Advisors, LLC | 11,577 | $7.93K | 0.00% |
| Venturi Wealth Management, LLC | 10,134 | $6.95K | 0.00% |
| Commonwealth Equity Services, LLC | 10,000 | $6.00K | 0.00% |
Sold out (8)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Sepio Capital, LP | 330,600 | $347.1K |
| Fermata Advisors, LLC | 28,547 | $30.0K |
| Stifel Financial Corp | 19,700 | $20.7K |
| Price T Rowe Associates Inc | 16,700 | $18.0K |
| Virtu Financial LLC | 12,532 | $13.0K |
| StoneX Group Inc. | 11,382 | $12.0K |
| Jane Street Group, LLC | 10,761 | $11.3K |
| Parallel Advisors, LLC | 2,963 | $3.11K |